Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).

Source:http://linkedlifedata.com/resource/pubmed/id/16199079

Download in:

View as

General Info

PMID
16199079